Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?

L Karayan-Tapon1, M Wager, J Guilhot

  • 1Université de Poitiers, EA 3805, CHU de Poitiers, 2 rue de la Milétrie, BP 577, Poitiers F-86021, France.

British Journal of Cancer
|September 11, 2008
PubMed

Related Concept Videos